Graves' disease (GD) is a multifactorial condition that is the result of a network of interactions between genetic and environmental factors, leading to the loss of immune tolerance to thyroid antigens (Hou et al., 2021). While genetic factors make up about 70-80% of the causes, environmental factors are the cause of 20-30% of the pathogenesis of autoimmune thyroid disease (AITD), including GD (Wiersinga, 2016). Moreover, endogenous factors also play a role in the development of GD.
Endogenous Factors
Sex
Since women are more susceptible to autoimmune diseases, there is a correlation that women are more likely to develop GD.
Age
GD shows the highest incidences in people aged between 20 and 40 years old. This means that people of this age group experience a higher risk while people outside of this range are not excluded from having the risk of developing this condition (News-Medical.net, 2012).
Pregnancy
Though statistics show that hyperthyroidism occurs in less than 1% of pregnant women, pregnant mothers are more at risk of having an overactive thyroid than non-pregnant women. This is because thyroid hormones are needed for the development of a foetus's nervous system, and they rely on the mother's supply of these hormones (National Institute of Diabetes and Digestive and Kidney Diseases, n.d.). Moreover, postpartum periods also increase the risk of the onset of Graves’ disease (Wiersinga, 2016).
Microbiota
Normally, symbiotic microbiota found in our gastrointestinal tracts benefits us by producing nutrients or enzymes that are necessary for our normal metabolism. However, when dysbiosis (imbalance of gut microbiota composition) occurs, it can alter the regulation of the immune system, causing various types of diseases, including autoimmune diseases like GD. The main gut flora changes that lead to GD are increased Prevotellaceae and Prevotella, Lactobacillus, as well as Veillonellaceae and Veillonella (Hou et al., 2021).
Genetic Factors
AITDs often run in families, and research proves having a family member who has AITD increases the chances of developing AITD yourself (Wiersinga, 2016). Moreover, race also plays into the susceptibility to GD as different races have been found to possess different polymorphisms of GD susceptibility genes (Ploski, Szymanski and Bednarczuk, 2011). Multiple genes have shown some correlation to the predisposition to GD.
Human Leukocytes Antigen (HLA) gene
This gene codes for HLA complexes that help our immune system recognise self vs non-self proteins. Variant forms of this gene (alleles) can either cause GD-like symptoms or have protective effects against GD. HLA-B*08:01, -C*07:01, and -DQB1*03:01 increase the risk of developing GD whereas HLA-DQB1*02 and -DRB1*07 protect against GD (Ploski, Szymanski and Bednarczuk, 2011; Stasiak et al., 2023).
Thyroid-specific genes (Ploski, Szymanski and Bednarczuk, 2011)
Thyroid-stimulating hormone receptor antibodies (TRAb) are the main serological manifestation of GD and they are almost detected exclusively in GD patients. Studies have found that single nucleotide polymorphism in TRAb genes increased the risk of GD in Caucasians with SNP rs2268458 alleles and in Asians with SNP rs2268458 alleles.
In addition, thyroglobulin (Tg) is also one of the self-antigens for GD. In contrast to TRAb, antibodies against Tg (TgAb) are not GD-specific as they are also found in 80-90% of other AITD conditions. Therefore, the presence of TgAb indicates AITD in general but not specifically GD.
Immunoregulatory genes
Several other susceptibility genes have been found to predispose to GD, most significantly PTPN22, CD40, CTLA4, and FCLR3.
Environmental Factors
These factors include lifestyle and dietary habits, as well as infections that may have caused damage to the thyroid.
Stress
There have been several case studies that demonstrate higher incidences of GD in the year following stressful life events. Be it emotional or physical stress, anxiety-causing events may act as a catalyst for the onset of GD in people with susceptibility genes (Mayo Clinic, 2020).
Drugs
Some drugs can induce AITDs including GD. These drugs include Interferon-α, alemtuzumab, and anti-retroviral therapy medications (Wiersinga, 2016).
Smoking
It has been found that smoking can raise the risk of GD about two-fold and the effect is dose-dependent, meaning that the more one smokes, the more likely one is predisposed to developing this disease; vice versa, the risk decreases within years after smoking is stopped (Wiersinga, 2016).
Selenium intake
Selenoprotein enzymes like glutathione reductase play a role in protecting our cells against oxidative damage caused by highly reactive species produced by our bodies like hydrogen peroxide. Since the thyroid gland consists of a high amount of selenium, evidence shows that low selenium levels are associated with poor immunity and hence, it is hypothesised that selenium deficiency may inflate the risk of thyroid immunity conditions such as GD (Wiersinga, 2016).
Vitamin D
Low vitamin levels have been linked with multiple autoimmune diseases. Research also shows that GD patients were likely to possess vitamin D deficiency. For example, the levels of thyroid peroxidase antibodies (antibodies that attack the thyroid gland) in women decreased from those with vitamin D deficiency to those with vitamin D sufficiency (Wiersinga, 2016).
Infection
Some bacterial or viral infections can induce the development of GD. For example, research has identified a positive correlation between Y. enterocolitica infection and GD. This is due to molecular mimicry displayed by this bacteria. One of its membrane proteins has been found to be involved in the production of thyroid-stimulating hormone (TSH) receptor antibodies, which also attack the thyroid gland, leading to GD (Wiersinga, 2016).
Fig above summarising the factors that affect the onset of GD.